REG - Competition and Mkts - CVS takeover of The Vet raises competition concern

CVSAnnouncement

18/02/2022 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220218:nRSR1157Ca&default-theme=true

RNS Number : 1157C  Competition and Markets Authority  18 February 2022

 

CVS takeover of The Vet raises competition concerns

 

CVS Group's completed purchase of The Vet could now be referred for an
in-depth investigation after finding that the deal raises competition
concerns.

 

The Competition and Markets Authority (CMA) opened its investigation into CVS
Group's purchase of Quality Pet Care, which trades as The Vet, in December
last year. Both firms are providers of veterinary services, with CVS Group
owning 467 practices in the UK, while The Vet operates eight practices across
England.

 

Recent reports indicate that there are 17 million pet-owning homes across the
UK, with consumer expenditure on vets and other services for pets in the UK
estimated to be around £4 billion between July 2020 and June 2021. In recent
years, the ownership of vets' practices across the UK has changed, with many
practices being acquired by a small number of corporate groups, such as CVS.
While independent veterinary practices accounted for 89% of the UK industry
in 2013, this share had fallen to less than half (45%) by 2021, primarily as
a result of independent practices being bought by corporate groups.

 

Following its Phase 1 investigation into CVS's acquisition of The Vet, the CMA
has found that the merger raises competition concerns in five local areas -
Bristol, Nottingham, Portsmouth, Southampton and Warrington.

 

The CMA's investigation found that the combined businesses would account for a
significant proportion of veterinary services in each of these areas. While
veterinary practices owned by CVS and The Vet currently compete for customers
at each of these locations, the CMA is concerned that the combined businesses
would not face sufficient competition after the merger. This could lead to pet
owners facing a worse quality of service, including more limited treatment
options, or having to pay higher prices.

 

Colin Raftery, Senior Director of Mergers, at the CMA, said:

 

"Pets are much-loved members of millions of households across the UK and, when
veterinary care is needed, it's important that pet owners have access to a
good service at the right price.

 

"The CMA has received a number of complaints in recent years about higher
prices or lower quality services as a result of too many vets' practices in
the same area being under the control of a single company.

 

"This deal could lead to customers facing more limited treatment choices for
their pets or paying over the odds for services in these areas. Should CVS
fail to address our concerns we will refer the deal for an in-depth
investigation."

 

CVS has 5 working days to offer legally-binding proposals to the CMA to
address the competition concerns identified. The CMA would then have a further
5 working days to consider whether to accept these instead of referring the
case to a Phase 2 investigation.

 

For more information, visit the CVS / Quality Pet Care merger inquiry page
(https://www.gov.uk/cma-cases/cvs-slash-quality-pet-care-merger-inquiry) .

 

Notes to Editors

1.   CVS refers to CVS Group plc, including its subsidiary CVS (UK) Limited,
and The Vet refers to Quality Pet Care Ltd (Quality Pet Care), trading as The
Vet.

2.   Following a Phase 1 review, the CMA has found that CVS's acquisition of
The Vet gives rise to a realistic prospect of substantial lessening of
competition (SLC) in the local areas around five of the eight practices
acquired by CVS, in Bristol, Nottingham, Portsmouth, Southampton and
Warrington.

3.   The information available to the CMA indicates that the combined
businesses of the CVS and The Vet would provide more than 30% of all
veterinary services in each of these five local areas.

4.   The CMA served an initial enforcement order in September 2021 requiring
the companies to operate independently, as they did before the purchase.  The
order remains in force. Details of the order can be found on the CVS / Quality
Pet Care merger inquiry page
(https://www.gov.uk/cma-cases/cvs-slash-quality-pet-care-merger-inquiry) .

5.   The CMA's investigation focused on the provision of commercial
veterinary services to small animals (including cats, dogs and other pets),
and excluded services for equine and farm animals (horses and livestock); the
CMA's investigation also excluded out of hours services and referral services,
as well as non-commercial practices in the market, such as charities.

6.   The Pet Food Manufacturer's Association found in its 2021 Pet
Population report (https://www.pfma.org.uk/pet-population-2021) that 17
million UK households had pets.

7.   ONS data
(https://www.ons.gov.uk/economy/nationalaccounts/satelliteaccounts/timeseries/adqt/ct)
suggests that in the year leading up to July 2021 consumer spending on vets
and other services for pets was over £4 billion.

8.   All media enquiries should be directed to the CMA press office by email
on press@cma.gov.uk (mailto:press@cma.gov.uk) , or by phone on 020 3738 6460.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MERTPMFTMTIBMTT